Ikarian Capital, LLC

SEC CIK: 0001778253
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

CCCC holding history

C4 Therapeutics, Inc. in every 13F filed by Ikarian Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CCCC overview All 13F holders of CCCC Full Q2 2026 holdings

Shares (Q2 2026): 2,433,000
Value: $11.4M
% of portfolio: 1.9%
Quarters held: 3; Since Q1 2021

Holdings of CCCC by Ikarian Capital, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	2,433,000	$11.4M	1.9%	+2,433,000	New	Holders
Q3 2021	0	$0	0.0%	−17,600−100.0%	Sold out	Holders
Q2 2021	17,600	$666.0K	0.1%	−93,900−84.2%	Reduced	Holders
Q1 2021	111,500	$4.12M	0.6%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.